Interpretable Artificial Intelligence across Scales for Next-Generation Cancer Prognostics

This project aims to enhance cancer prognosis and treatment selection by applying advanced machine learning to whole-slide images, addressing key knowledge gaps and improving model explainability.

Subsidie
€ 1.494.810
2022

Projectdetails

Introduction

Computation pathology has the potential to revolutionize cancer care and research, specifically through improving assessment of patient prognosis and treatment selection by applying advanced machine learning methods to digitized tissue sections, i.e. whole-slide images (WSIs). This will allow us to replace the current state-of-the-art of human-developed cancer grading systems.

Challenges in the Field

However, the field is currently hindered by significant knowledge gaps:

  1. We do not know how to effectively leverage both global and local information in WSIs.
  2. We do not know how to identify pan-cancer prognostic features.
  3. We do not know how to make machine learning models explainable and interpretable.

Project Objectives

In this project, I will address these key knowledge gaps by building on the novel stochastic streaming gradient descent (SSGD) developed in my group.

Methodology

Specifically, I will:

  • Integrate innovative multi-task and cross-task learning algorithms with SSGD.
  • Leverage the latest advances in self-supervision, self-attention, and natural language processing to endow deep neural networks with unprecedented transparency and explainability.

Validation and Impact

Last, the project will validate our developed methodology in the largest dataset of oncological WSIs in the world. For the first time, it will identify links between morphological prognostic features and genetic features.

Scientific Contribution

By publicly releasing all developed tools and data, the proposed project will have a scientific multiplier effect for the fields of oncology, computational pathology, and machine learning.

Applications

Specifically, the derived cancer-specific and pan-cancer biomarkers can be leveraged in:

  • Clinical care
  • Cancer research

Additionally, the enhanced SSGD method for other tasks in computational pathology and our novel multi-task and explainability algorithms can impact other research areas in machine learning, such as:

  • Remote sensing
  • Self-driving cars

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 1.494.810
Totale projectbegroting€ 1.494.810

Tijdlijn

Startdatum1-4-2022
Einddatum31-3-2027
Subsidiejaar2022

Partners & Locaties

Projectpartners

  • STICHTING RADBOUD UNIVERSITAIR MEDISCH CENTRUMpenvoerder

Land(en)

Netherlands

Vergelijkbare projecten binnen European Research Council

ERC STG

MANUNKIND: Determinants and Dynamics of Collaborative Exploitation

This project aims to develop a game theoretic framework to analyze the psychological and strategic dynamics of collaborative exploitation, informing policies to combat modern slavery.

€ 1.497.749
ERC STG

Elucidating the phenotypic convergence of proliferation reduction under growth-induced pressure

The UnderPressure project aims to investigate how mechanical constraints from 3D crowding affect cell proliferation and signaling in various organisms, with potential applications in reducing cancer chemoresistance.

€ 1.498.280
ERC STG

Uncovering the mechanisms of action of an antiviral bacterium

This project aims to uncover the mechanisms behind Wolbachia's antiviral protection in insects and develop tools for studying symbiont gene function.

€ 1.500.000
ERC STG

The Ethics of Loneliness and Sociability

This project aims to develop a normative theory of loneliness by analyzing ethical responsibilities of individuals and societies to prevent and alleviate loneliness, establishing a new philosophical sub-field.

€ 1.025.860

Vergelijkbare projecten uit andere regelingen

ERC COG

Trustworthy AI tools for personalized oncology

The project aims to develop trustworthy AI tools for personalized oncology to enhance diagnosis, outcome prediction, and treatment recommendations, ensuring reliability and transparency in clinical practice.

€ 1.999.225
ERC POC

AI-based leukemia detection in routine diagnostic blood smear data

Develop LeukoScreen, an AI software to enhance the speed and accuracy of acute promyelocytic leukemia diagnosis, improving patient outcomes and optimizing laboratory workflows.

€ 150.000
ERC COG

Integrated Mechanistic Modelling and Analysis of Large-scale Biomedical Data

INTEGRATE aims to enhance cancer treatment by developing advanced computational models that integrate patient-derived data for improved drug targeting and clinical trial planning.

€ 1.854.546
ERC COG

Foundation models for molecular diagnostics - machine learning with biological ‘common sense’

FoundationDX aims to enhance molecular diagnostics by using self-supervised learning on diverse biomolecular data to accurately predict cancer subtypes and treatment outcomes without extensive labeled datasets.

€ 2.000.000